Idiopathic Constipation
📧 Sign up to get email alerts when something new happens for Idiopathic Constipation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-07-25FDA Approved: TRULANCE IMMEDIATE RELEASE — Supplemental Application (Salix Pharmaceuticals Inc.)
The FDA approved a Supplemental Application for TRULANCE IMMEDIATE RELEASE (plecanatide) from Salix Pharmaceuticals Inc. This action concern…
-
FDA approval · 2018-04-26FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories Inc.
-
FDA approval · 2018-01-24FDA Approved: TRULANCE IMMEDIATE RELEASE — Supplemental Application (Salix Pharmaceuticals Inc.)
FDA approved a supplemental application for an immediate-release formulation of Trulance (plecanatide) from Salix Pharmaceuticals, expanding…
-
FDA approval · 2017-01-19FDA Approved: TRULANCE IMMEDIATE RELEASE — Original Application (Salix Pharmaceuticals Inc.)
The FDA approved Trulance immediate-release (plecanatide) from Salix Pharmaceuticals in an original NDA for the treatment of chronic idiopat…
-
FDA approval · 2017-01-06FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Linzess (linaclotide) filed by Allergan, expanding its regulatory status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-10-11FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone from Dr. Reddy's Laboratories Inc., typically reflecting updates to labeling or ind…
-
FDA approval · 2016-05-18FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA has approved a supplemental application for Linzess (linaclotide) from Allergan, expanding the labeling for the product.
-
FDA approval · 2016-04-06FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for LINZESS (linaclotide).
-
FDA approval · 2015-11-23FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for LINZESS (linaclotide) submitted by Allergan, Inc. This action updates the regulatory status …
-
FDA approval · 2015-01-05FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Linzess (linaclotide) from Allergan, Inc., indicating agency approval of a supplemental NDA …
-
FDA approval · 2014-12-11FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Linzess (linaclotide) from Allergan, expanding its labeling.
-
FDA approval · 2014-07-09FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Linzess (linaclotide) filed by Allergan, Inc.
-
FDA approval · 2013-08-19FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2013-08-08FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Linzess (linaclotide) from Allergan, Inc., resulting in an updated labeling or indication fo…
-
FDA approval · 2013-04-19FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories Inc.
-
FDA approval · 2012-11-26FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone submitted by Dr. Reddy's Laboratories.
-
FDA approval · 2012-08-30FDA Approved: LINZESS — Original Application (Allergan, Inc.)
The FDA approved Linzess (linaclotide) through its Original Application by Allergan, establishing its use for adults with irritable bowel sy…
-
FDA approval · 2008-04-29FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories Inc., indicating an update to the product lab…